GI
FENC icon

GAMMA Investing’s Fennec Pharmaceuticals FENC Stock Holding History

GAMMA Investing’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75K Buy
349
+265
+315% +$2.16K ﹤0.01% 3587
2026
Q1 		$517 Sell
84
-29
-26% -$224 ﹤0.01% 3944
2025
Q4 		$870 Hold
113
– – ﹤0.01% 3819
2025
Q3 		$1.06K Hold
113
– – ﹤0.01% 3604
2025
Q2 		$938 Buy
113
+3
+3% +$21 ﹤0.01% 3544
2025
Q1 		$670 Buy
+110
New +$706 ﹤0.01% 3634

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GAMMA Investing's FENC Position: Q2 2026 in Review

GAMMA Investing increased its Fennec Pharmaceuticals (FENC) stake by 315% in Q2 2026, buying an estimated $2.16K and bringing the position to 349 shares worth $3.75K. The position accounts for ﹤0.01% of the portfolio, ranked #3587.

GAMMA Investing first reported a position in FENC in Q1 2025 and has held it in 6 quarters since. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • GAMMA Investing held 349 shares of Fennec Pharmaceuticals worth $3.75K as of Q2 2026.
  • GAMMA Investing bought 265 Fennec Pharmaceuticals shares in Q2 2026, an estimated $2.16K.
  • Fennec Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3587 holding.
  • GAMMA Investing first reported a position in Fennec Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.